Gideon Obasanmi, MRes, PhD

Dr Gideon Obasanmi completed a PhD in Experimental Ophthalmology and a Master of Research (MRes) in Molecular Medicine at Queen’s University Belfast, NI, UK before joining the Personalised Medicine/Experimental Ophthalmology team at Ulster University, NI, UK.

At Ulster University, Dr Obasanmi and his team successfully repurposed a novel peptide shown to be safe in cancer clinical trials for therapeutic use in ophthalmology. Dr Obasanmi’s research experience cuts across research labs in North America, Africa and Europe and his expertise is in the mechanisms of neovascular eye diseases, developing preclinical eye disease models and drug repurposing.

Contact: gideon.obasanmi@ubc.ca